Anitox appoints new chief financial officer
Dave Smith has joined pathogen control specialist Anitox as chief financial officer.
This latest appointment comes at a pivotal point in the companies expansion plans as it looks to move into new markets, launch new products and consolidate its global leader positioning.
“Anitox’s impressive growth and ambitious attitude towards breaking into new markets is what really excites me,” says Smith.
“I was looking for a new challenge that not only allowed me to apply my own experience, knowledge and skillset to my job role, but also for a company that is fast paced and has a hunger for seeking new business opportunities.
“For me, that company is Anitox,” adds Smith. With the company looking to double in size over the next three years, Anitox chief executive officer, Rick Phillips, has emphasised the fundamental role Smith has to play.
“Daves appointment has come at a crucial time,” comments Phillips , “As we look to explore new business opportunities with our BioFuels program and with the launch of our latest Finio product, we need the right people behind us to maintain our high level of financial operating and planning, Dave fits that bill.”
Previously holding the role of CFO at AMRest US, Smith has worked with several large and medium sized multinational companies serving in both senior finance and operational roles.
Related link:
